Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amani Mahroug
Observed name:
Mahroug, Amani
Institutions:
Centre Hospitalier de l’Université de Montréal,
Université de Montréal
Observed institutions:
Institut universitaire en santé mentale de Montréal,
Centre Hospitalier de l’Université de Montréal,
Université de Montréal
ORCID:
0009-0008-2069-4552
Observed ORCID:
0009-0008-2069-4552
OpenAlex ID:
A5032084757
The effectiveness of an online short-format Recovery College model: a co-learning model to support mental health
2024
·
Catherine Briand
, Charles-Édouard Giguère
, et al.
·
International Journal of Mental Health Systems
·
20
Measurement of Impulsivity and Its Role in Drug Use Behaviours and Related Health, Harm and Treatment Outcomes Among People Who Use Illicit Drugs—A Scoping Review
2025
·
Iuliia Makarenko
, Amani Mahroug
, et al.
·
International Journal of Mental Health and Addiction
·
10
PDF
Digital health technology adoption factors: a rapid review of systematic reviews and checklist development
2025
·
Tokiko Hamasaki
, Catherine Briand
, et al.
·
Disability and Rehabilitation Assistive Technology
·
8
Is Naltrexone Effective and Safe for Treating Amphetamine-Type Stimulant Use Disorder? A Systematic Review and Meta-analysis
2024
·
Gabriel Bastien
, Christina McAnulty
, et al.
·
Journal of Addiction Medicine
·
4
Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d’opioïdes vendus sur ordonnance
2025
·
Gabriel Bastien
, Anita Abboud
, et al.
·
The Canadian Journal of Psychiatry
·
3
Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder: Exploratory Findings from a Randomized Controlled Trial
2024
·
Francois-Olivier Hebert
, Violaine Mongeau-Pérusse
, et al.
·
Cannabis and Cannabinoid Research
·
3
Utilization of Recovery-Oriented Practices Among Mental Health Practitioners Working With Carers
2025
·
Yifan Wang
, Juliette Nadeau-Tremblay
, et al.
·
Canadian Journal of Community Mental Health
·
2
Does co-administration of cannabidiol (CBD) influence the plasma availability of delta-9-tetrahydrocannabinol (THC) and its active metabolite in humans? A systematic review and meta-analysis
2026
·
Lucy A. Chester
, Heidar Sharafi
, et al.
·
Neuroscience & Biobehavioral Reviews
·
1
PDF
Acute behavioural effects of low-dose cannabidiol: A randomised crossover trial in healthy volunteers
2026
·
Lucy A. Chester
, François-Olivier Hebert
, et al.
·
Journal of Psychopharmacology
·
1
Correlates of Engagement and Associations With Outcomes in a Cannabis Harm-Reduction Mobile App for Youth With First-Episode Psychosis: Exploratory Analysis of the CHAMPS Pilot Randomized Controlled Trial
2026
·
Amani Mahroug
, Pamela Lachance-Touchette
, et al.
·
JMIR Formative Research
Acute Behavioural Effects of Low-dose Cannabidiol in Healthy Volunteers
2025
·
Lucy Chester
, Francois-Olivier Hébert
, et al.
·
Drug and Alcohol Dependence
Athroprotective and Atheroregressive Potential of an [aza-Y4]-GHRP-6 Analogue, a Selective CD36 Ligand, in Apolipoprotein E-deficient Mice
2018
·
Geneviève Frégeau
, Roger Sarduy
, et al.
·
Atherosclerosis Supplements
Show more works
View as search
Works count:
13
Citation count:
52
H-index:
4
I10-index:
2
Year
Topic
Type